LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 78.60 | 27.76 | 10335 | 7045 | 1.4668 | 1.0983 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 80.31 | 27.76 | 850 | 6976 | 0.1218 | 0.5359 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 80.31 | 27.76 | 11087 | 6976 | 1.5893 | 1.1196 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 80.31 | 27.76 | 1948 | 6976 | 0.2792 | 0.7043 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 80.31 | 27.76 | 10495 | 6976 | 1.5044 | 1.1051 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 82.01 | 27.76 | 968 | 7000 | 0.1383 | 0.5608 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 82.01 | 27.76 | 11319 | 7000 | 1.6169 | 1.1242 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 82.01 | 27.76 | 2165 | 7000 | 0.3093 | 0.7264 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 82.01 | 27.76 | 10701 | 7000 | 1.5286 | 1.1093 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 83.72 | 27.76 | 740 | 7055 | 0.1049 | 0.5082 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 83.72 | 27.76 | 11529 | 7055 | 1.6340 | 1.1268 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 83.72 | 27.76 | 1954 | 7055 | 0.2769 | 0.7031 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 83.72 | 27.76 | 10917 | 7055 | 1.5473 | 1.1123 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 85.42 | 27.76 | 887 | 7025 | 0.1263 | 0.5433 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 85.42 | 27.76 | 11668 | 7025 | 1.6608 | 1.1312 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 85.42 | 27.76 | 1949 | 7025 | 0.2774 | 0.7033 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 85.42 | 27.76 | 11053 | 7025 | 1.5732 | 1.1168 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 87.13 | 27.76 | 888 | 6987 | 0.1271 | 0.5442 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 87.13 | 27.76 | 11979 | 6987 | 1.7143 | 1.1398 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 87.13 | 27.76 | 1915 | 6987 | 0.2741 | 0.7004 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 87.13 | 27.76 | 11307 | 6987 | 1.6181 | 1.1244 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 88.84 | 27.76 | 955 | 6965 | 0.1371 | 0.5587 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 88.84 | 27.76 | 12155 | 6965 | 1.7452 | 1.1447 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 88.84 | 27.76 | 1969 | 6965 | 0.2827 | 0.7069 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 88.84 | 27.76 | 11420 | 6965 | 1.6396 | 1.1280 | MN20160318_Q01 | M15 |